Loading...
•
Sep 30, 2024
Merit Medical Q3 2024 Earnings Report
Merit Medical's Q3 2024 results were reported, with revenue up 7.8% and full-year guidance raised.
Key Takeaways
Merit Medical reported better-than-expected financial results in Q3 2024, with revenue increasing by 7.8% to $339.8 million. The company saw improvements in non-GAAP operating margin and non-GAAP EPS, and generated $120 million in free cash flow over the first nine months of 2024. Updated financial guidance for fiscal year 2024 reflects stronger-than-expected organic growth and profitability.
Reported revenue of $339.8 million, up 7.8%.
GAAP operating margin of 11.0%, compared to 11.1% in prior year period.
GAAP EPS $0.48, up 8.0%, and non-GAAP EPS $0.86, up 21.1%.
Completed the acquisition of certain assets from EndoGastric Solutions, Inc.
Forward Guidance
Merit Medical updated its fiscal year 2024 financial guidance to reflect the stronger-than-expected organic growth and profitability results to-date. The updated guidance continues to assume the forecasted impacts from the acquisition of EndoGastric Solutions and the projected impacts from the acquisition of assets from Cook Medical.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...